Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer

Summary

Current therapies for Stage III or IV Ovarian Cancer provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Stage III or IV Ovarian Cancer. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Stage III or IV Ovarian Cancer.

Timeline

Start

1996-03-05

Primary completion

2002-10-18

Completion

2002-10-18

Drugs

Indications